Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | MPO | P05164 | 2/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.53 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.53 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.53 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.53 |
| ▸ | FEN1 | P39748 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12862594 | 0.88 | ALDH1A1 (0.73) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL8987555 | 0.85 | CYP1A2 (0.65) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL7022854 | 0.84 | CYP1A2 (0.59) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL6983105 | 0.82 | CYP1A2 (0.61) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL9299629 | 0.80 | FEN1 (0.57) | CYP1A2MPOFEN1MEN1KMT2A | |
| SCHEMBL9523849 | 0.79 | CYP1A2 (1.00) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL5514563 | 0.78 | CYP1A2 (0.63) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL6979328 | 0.77 | CYP1A2 (0.62) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL17474543 | 0.77 | CYP1A2 (0.61) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL1662185 | 0.76 | ALDH1A1 (0.68) | CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002074945-A1 | METHOD FOR CLEAVING HUMAN GROWTH HORMONE GH | IBFB GMBH PRIVATES INSTITUT FÜR BIOMEDIZINISCHE FORSCHUNG UND BERATUNG (DE) | 2002-09-26 | — | — | WO | claimed |
| US-5306721-A | Immunostimulants, viricides | ARZNEIMITTELERK DRESDEN G.M.B.H. (DE) | 1994-04-26 | — | — | US | claimed |
| US-20040259192-A1 | Method for cleaving the human growth hormone gh | IBFB GMBH PRIVATES INSTITUT FUR BIOMEDIZINISCHE FORSCHUNG UND BERATUNG (DE) | 2004-12-23 | — | — | US | disclosed |
| WO-2002074945-A1 | METHOD FOR CLEAVING HUMAN GROWTH HORMONE GH | IBFB GMBH PRIVATES INSTITUT FÜR BIOMEDIZINISCHE FORSCHUNG UND BERATUNG (DE) | 2002-09-26 | — | — | WO | disclosed |
| EP-0454060-B1 | 3-(Mercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, processes for their preparation, and pharmaceutical compositions | DROESSLER KARL PROF DR (DE) | 1996-07-03 | — | — | EP | disclosed |
| US-5306721-A | Immunostimulants, viricides | ARZNEIMITTELERK DRESDEN G.M.B.H. (DE) | 1994-04-26 | — | — | US | disclosed |
| EP-0454060-A1 | 3-(Mercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, processes for their preparation, and pharmaceutical compositions | ARZNEIMITTELWERK DRESDEN GmbH (DE) | 1991-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259192-A1 | Method for cleaving the human growth hormone gh | MMP3, MMP25, MMP17 | CYP1A2 2974/4885ALDH1A1 3457/4885HPGD 355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.